These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16723601)

  • 1. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone.
    Park HS; Kim HJ; Seol MJ; Choi DR; Choi EC; Kwak JH
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2261-4. PubMed ID: 16723601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
    Kwon AR; Min YH; Ryu JM; Choi DR; Shim MJ; Choi EC
    J Antimicrob Chemother; 2006 Sep; 58(3):684-8. PubMed ID: 16873394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone.
    Fujikawa K; Chiba M; Tanaka M; Sato K
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3040-5. PubMed ID: 15980395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M; Coll R; Esteve M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms.
    Almer LS; Hoffrage JB; Keller EL; Flamm RK; Shortridge VD
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2771-7. PubMed ID: 15215148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of trovafloxacin (CP-99,219) against 434 bacterial strains: comparative study with other fluoroquinolones].
    Tali-Maamar H; Tebbal S; Rahal K
    Arch Inst Pasteur Alger; 1998; 62():52-61. PubMed ID: 11256319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.
    Oh JI; Paek KS; Ahn MJ; Kim MY; Hong CY; Kim IC; Kwak JH
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1564-8. PubMed ID: 8726042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and in-vivo activities of DW-116, a new fluoroquinolone.
    Choi KH; Hong JS; Kim SK; Lee DK; Yoon SJ; Choi EC
    J Antimicrob Chemother; 1997 Apr; 39(4):509-14. PubMed ID: 9145824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
    Montanari MP; Mingoia M; Varaldo PE
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3616-22. PubMed ID: 11709353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of BMY 45243, a new 5-amino-naphthyridone derivative.
    Bouzard D; Di Cesare P; Hoffmann P; Fung-Tomc J; Kessler R
    Drugs Exp Clin Res; 1992; 18(7):291-4. PubMed ID: 1338310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
    Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone.
    Cormican MG; Jones RN
    Antimicrob Agents Chemother; 1997 Jan; 41(1):204-11. PubMed ID: 8980783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
    Cuffini AM; Tullio V; Vaiani G; Carlone NA
    J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
    [No Abstract]   [Full Text] [Related]  

  • 17. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
    Hoban D; Grabowski M; Koss J; Weselowski V
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate.
    Yamaguchi K
    J Infect Chemother; 2001 Dec; 7(4):205-17. PubMed ID: 11810586
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV; Ho DH; LeBlanc B; Bodey GP
    Chemotherapy; 1990; 36(5):365-72. PubMed ID: 2209169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria.
    Bowker KE; Wootton M; Holt HA; Reeves DS; MacGowan AP
    J Antimicrob Chemother; 1996 Aug; 38(2):271-81. PubMed ID: 8877542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.